Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guided withdrawal of inhaled corticosteroids in primary care COPD patients without a clear ICS indication
NL-OMON42531Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2015
- Countries
- 1
01
Overview
Open-label trial in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Number of exacerbation-free weeks. Started Dec 2015; status: active, not recruiting.
02
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON42531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42531.